GlassScriptPhysician profile
Salvatore Bordonaro
NPI 1821337759
$5,058.87
in general payments reported to CMS, 2019-2025
9 companies · $4,209 in 2025
The $4,209 reported for 2025 was more than what 97% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $224 · 2023: $358 · 2024: $48.60 · 2025: $4,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,402 · Food and Beverage: $684 · Travel and Lodging: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,402.00 |
| Food and Beverage | $684.28 |
| Travel and Lodging | $529.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $4,126.50 | 2025 | Veozah |
| Rochester Medical Corporation | $304.95 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $207.91 | 2023 | Bard Urinary Drainage Bag |
| Antares Pharma, INC. | $138.35 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $134.09 | 2023-2024 | Jynarque |
| 180 Medical, INC. | $58.39 | 2023-2025 | Gentlecath |
| Becton, Dickinson and Company | $52.87 | 2025 | Spirit Hydrocolloid Adhesive Sheath, Bard Urinary Drainage Bag |
| Travere Therapeutics, INC. | $20.24 | 2023 | |
| Novartis Pharmaceuticals Corporation | $15.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salvatore Bordonaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.